Diabetes Research and Clinical Practice
07/31/2002 By Andrew A. Skolnick
Treating type 2 diabetics with the angiotensin-II receptor antagonist valsartan may reduce urinary albumin excretion, even at doses that are too low to affect the patients’ blood pressure.
K. Suzuki and colleagues at the Niigata Graduate School of Medical and Dental Sciences in Niigata, Japan, treated 40 patients with type 2 diabetes with valsartan at a dose (40 mg), too low to lower their blood pressure
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!